Resources, Articles, Case Studies


Resources

 

What is Engaged Thinking? How can it be applied within your organizational context?
Download The Engaged Thinking Map...

Understand the consumer's journey to better design products and services for
engagement.
Download The Consumer Journey Map...


Does your organization's culture encourage and support learning?
Download the Learning Culture Audit...

How does stage of development and consumer need impact the goals of innovation?
Download Engaging for Behaviour Change...


Articles  



Managing Intellectual Capital Assets
Novel models of collaboration including pre-discovery consortia, R&D networks, centers of excellence, public-private partnerships, crowd-sourcing and web-based collaboration platforms are increasingly being sought for drug discovery and development activities. The opportunity to employ these emerging models of open innovation is not only determined by organizational structure and size, but equivalently by the goals of the endeavor namely—knowledge creation, dissemination, shared governance of intellectual assets, and the engagement of human capital across organizational boundaries. Read More...

Exploring Open Innovation with a Patient Focus in Drug Discovery: An Evolving Paradigm of Patient Engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design. Read More...


Engaging Patients for Drug Repurposing: Mapping the Patient Engagement Continuum

The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing. Read More...

Resources

 

What is Engaged Thinking? How can it be applied within your organizational context?
Download The Engaged Thinking Map...

Understand the consumer's journey to better design products and services for
engagement.
Download The Consumer Journey Map...


Does your organization's culture encourage and support learning?
Download the Learning Culture Audit...

How does stage of development and consumer need impact the goals of innovation?
Download Engaging for Behaviour Change...


Articles  



Managing Intellectual Capital Assets
Novel models of collaboration including pre-discovery consortia, R&D networks, centers of excellence, public-private partnerships, crowd-sourcing and web-based collaboration platforms are increasingly being sought for drug discovery and development activities. The opportunity to employ these emerging models of open innovation is not only determined by organizational structure and size, but equivalently by the goals of the endeavor namely—knowledge creation, dissemination, shared governance of intellectual assets, and the engagement of human capital across organizational boundaries. Read More...

Exploring Open Innovation with a Patient Focus in Drug Discovery: An Evolving Paradigm of Patient Engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design. Read More...


Engaging Patients for Drug Repurposing: Mapping the Patient Engagement Continuum

The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing. Read More...